Company intelligence / Profile preview
Shanghai Shyndec Pharmaceutical
- Ownership
- Private
- Employees
- ~11472
- Development stage
- Commercial
Overview
Shanghai Shyndec Pharmaceutical has a broad commercial portfolio with over 200 APIs and numerous finished dosage forms. The company has multiple approved drugs in China and internationally for indications such as hypertension and influenza. It continues to expand its pipeline through significant R&D investment (~$80–100 million/year), aiming to develop new drug candidates annually. Recent regulatory approvals include anti-tumor injections and hypertension therapies.
- Therapeutic areas
- GastroenterologyCardiovascularRheumatologyOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculeHerbal medicineSynthetic peptideChemical drugContrast agent
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Shanghai Shyndec Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Shyndec Pharmaceutical.